20
Centrient Pharmaceuticals Netherlands B.v. Delft Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
One of their significant offerings is Cefalexin monohydrate, Powder, compacted, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1997-007 - Rev 07
This Chemical Type CEP, issued on March 21, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 708 associated with this CEP further emphasizes